Continuous Manufacturing of Recombinant Drugs: Comprehensive Analysis of Cost Reduction Strategies, Regulatory Pathways, and Global Implementation

Kaydedildi:

Detaylı Bibliyografya
Yayımlandı:	Pharmaceuticals vol. 18, no. 8 (2025), p. 1157-1189
Yazar:	Niazi, Sarfaraz K
Baskı/Yayın Bilgisi:	MDPI AG
Konular:	Food & Drug Administration > FDA United States > US Germany Monoclonal antibodies Product quality Collaboration Real time Batch processes Process controls Biological products Pharmaceutical industry Capital expenditures Batch processing Manufacturing Cost control 19th century Product testing
Online Erişim:	Citation/Abstract Full Text + Graphics Full Text - PDF
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

İlk yorumlayan siz olun!